A detailed history of Ra Capital Management, L.P. transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 22,748,880 shares of VOR stock, worth $19.8 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
22,748,880
Previous 22,748,880 -0.0%
Holding current value
$19.8 Million
Previous $22.7 Million 30.0%
% of portfolio
0.22%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.0 - $2.2 $22.7 Million - $50 Million
22,748,880 New
22,748,880 $22.7 Million
Q4 2023

Feb 14, 2024

BUY
$1.66 - $2.63 $37.8 Million - $59.8 Million
22,748,880 New
22,748,880 $51.2 Million
Q4 2022

Feb 14, 2023

BUY
$3.77 - $7.43 $43.8 Million - $86.4 Million
11,627,907 Added 104.56%
22,748,880 $151 Million
Q1 2021

May 17, 2021

BUY
$30.96 - $54.08 $344 Million - $601 Million
11,120,973 New
11,120,973 $479 Million

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $33.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.